Celldex Therapeutics (CLDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2004 | 12-2003 | 12-2002 | 12-2001 | 12-2000 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 31,742 | 18,251 | 25,071 | 42,666 | 50,177 |
| Marketable Securities | N/A | 2,000 | N/A | N/A | N/A |
| Receivables | 2,230 | 1,473 | 231 | 267 | 154 |
| Inventories | N/A | N/A | N/A | 72 | 59 |
| Other current assets | 0 | 0 | 0 | 0 | 396 |
| TOTAL | $34,540 | $22,309 | $25,860 | $43,343 | $51,807 |
| Non-Current Assets | |||||
| PPE Net | 4,164 | 913 | 1,120 | 988 | 1,038 |
| Intangibles | 7,100 | 8,083 | 8,254 | 9,154 | 10,719 |
| TOTAL | $11,264 | $8,996 | $9,373 | $10,141 | $11,756 |
| Total Assets | $45,804 | $31,305 | $35,233 | $53,485 | $63,563 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,752 | 476 | 836 | 1,130 | 902 |
| Accrued Expenses | 3,342 | 1,453 | 2,099 | 2,733 | 2,682 |
| Other current liabilities | 187 | N/A | N/A | N/A | N/A |
| TOTAL | $5,292 | $3,385 | $3,433 | $5,523 | $5,398 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 12 | 1,456 | 498 | 1,660 | 1,540 |
| Other Non-Current Liabilities | 2,104 | 0 | 0 | 0 | 0 |
| TOTAL | $2,104 | $N/A | $456 | $2,693 | $4,233 |
| Total Liabilities | $7,396 | $3,385 | $3,889 | $8,216 | $9,631 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 412 | 411 | 336 | 336 | N/A |
| Common Shares | 74 | 65 | 61 | 60 | 57 |
| Retained earnings | -217,776 | -204,572 | -191,903 | -178,073 | -155,320 |
| Other shareholders' equity | -1,721 | -1,217 | -136 | 0 | 0 |
| TOTAL | $38,408 | $27,920 | $31,344 | $45,269 | $53,932 |
| Total Liabilities And Equity | $45,804 | $31,305 | $35,233 | $53,485 | $63,563 |